GENERAL COMMENTS
The manuscript by Messer et al. investigated the putative role of the T300A polymorphism in ATG16L1, found to be genetically associated with Crohn's Disease, in the host response against Salmonella infection. The major strength of this work is the fact that the authors have used a perfectly clean genetic system to study the role of the T300A variant, by either deleting ATG16L1 or by creating a knock-in variant at the AA 300 position, using homologous recombination in a cell line (human intestinal HCT116). Using these cellular tools, the investigation of Salmonella entry and replication remained unfortunately preliminary in this study. However, these results are nonetheless of interest, as they provide some further information regarding the potential role of ATG16L1 T300A variant in the control of Salmonella infection, a question that remains unclear in the literature. Figure 4 , the authors have adjusted the multiplicity of infection in order to take into account the lesser entry of Salmonella in T300A cells or if they did not do that. If they did not do so, why is it that the CFUs at 1h p.i. are not very different between 300T and 300A?
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GENERAL COMMENTS
The goal of this paper by Messer et al. is to examine how the Crohn's disease (CD) variant in ATG16L1 affects entry of Salmonella Typhimurium into human intestinal epithelial cells. Accordingly, the findings show that somatically-targeted mutants in ATG16L1 are resistant to Salmonella enty.
The results in this paper are very exciting since the work uses a new model to study the CD variant of ATG16L1, the T300A variant. Little is know how this variant is linked with CD. Intriguingly, their findings point to the idea that this variant results in a cell that is resistant to bacterial infection. For the bacteria that are able to enter, these bacteria are not efficient cleared. Overall, while the paper is concise, it is an important observation and would be of interest to the IBD community.
Minor points: Figure 1 : is induced autophagy affected in these cells if they are treated with rapamycin?
VERSION 1 -AUTHOR RESPONSE
We have changed the title to focus on the research question as suggested.
We have added the letters as suggested
The data in 2A represent Salmonella invasion of cells in routine culture. The data in 2B show invasion of cells grown on transwells to more closely reflect polarized state of IEC in vivo. The data in 2B is statistically significant (the asterix to indicate this was omitted in the first submission and has been added here).
No we did not adjust the MOI but we did observe a 50% reduction in the number of Salmonella in ATG16L1 deficient and ATG16L1 T300A cells at the 1 hour time point in figure 4 . This was consistent with our data for the invasion assays shown in figure 2, but was not statistically significant in our ANOVA tests owing to the broad range and high numbers of Salmonella recovered from cells at 8 and 12 hours post infection.
We have not observed robust autophagy in response to rapamycin in this cell type. Starvation induced autophagy is normal in the ATG16L1 T300A cells.
